By integrating these insights, this work aims to deepen the mechanistic understanding of researchers and clinicians regarding the dual roles of cGAS-STING in breast cancer pathogenesis, ultimately paving the way for novel precision therapeutic strategies tailored to the molecular heterogeneity of the disease. Here, STING1 is linked to breast carcinoma.